Filing Flows › Xylem (XYL) › Q1 2025
Xylem (XYL) Q1 2025 earnings results (first quarter 2025)
10-Q filed Apr 29, 2025
Xylem (XYL) reported revenue of $2.1B for the first quarter 2025 (Q1 2025), +2% from a year earlier and -8% from the quarter before. Operating margin was 11.2%, net earnings $167M (8.1% of revenue).
Xylem, Q1 2025: revenue $2.1B (+2% year over year), operating margin 11.2%, net earnings $167M, operating cash flow $33.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1B | -8% | +2% |
| Gross profit | $768M | -10% | +2% |
| Operating profit | $231M | -13% | +11% |
| Net earnings | $167M | -49% | +9% |
| Operating cash flow | $33.0M | -94% | -63% |
What changed
Revenue was $2.1B in Q1 2025, up 2% year over year and down 8% from the previous quarter. Revenue from products was the largest line at 83% of revenue. Revenue from products added $0.02B year over year (up 1%), 53% of the total change.
Gross margin was 37.1%, up 0.1 points from a year earlier. Operating profit was $0.23B, a 11.2% margin (up 0.9 points year over year). Of the extra revenue versus a year earlier, 61% reached operating profit, above the 10% margin then. Operating expenses fell 1% while revenue rose 2%. The fastest-growing cost line was Other operating costs (+110%). Net earnings were $0.17B, up 10% year over year. The effective tax rate was 23.0%.
Operating cash flow was $0.03B (down 63% year over year), 20% of net earnings. Non-cash charges added back $0.14B of depreciation and amortization and $0.01B of share-based compensation. Working capital and other items used $0.29B. Capital expenditures of $0.07B exceeded it, leaving free cash flow of −$0.04B.
Questions
What was Xylem's revenue in the first quarter 2025?
Xylem (XYL) reported revenue of $2.1B for the first quarter 2025 (Q1 2025), +2% from a year earlier and -8% from the quarter before.
Was Xylem profitable in the first quarter 2025?
Operating profit was $231M (11.2% of revenue) and net earnings $167M.
Source: Xylem 10-Q on SEC EDGAR.